SNU Open Repository and Archive: Browsing S-Space

Browse

S-Space

Browsing by Author Lee, Dae Ho

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 14 of 14

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2003-01	Induction chemotherapy followed by radiotherapy in the treatment of anal cancer Lee, Dae Ho; Kim, Inho; Song, Hun Ho; Jung, Joo Young; Kim, Dae Young; Lee, Keun Wook; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Ha, Sung Whan; Park, Jae-Gahb; Kim, Noe Kyeong Oncology Reports, Vol.10 No.1, pp.101-104	DOI
2006-11	Epidermal growth factor receptor status in anaplastic thyroid carcinoma Lee, Dae Ho; Lee, Geon Kook; Kong, Sun-Young; Kook, Myoung Chul; Yang, Sun Kyung; Park, So Yeon; Park, Seong Hoe; Keam, Bhumsuk; Park, Do Joon; Cho, Bo Youn; Kim, Seok Won; Chung, Ki-Wook; Lee, Eun Sook; Kim, Sun Wook J Clin Pathol 2007;60:881-4	view file DOI
2006-11	Epidermal growth factor receptor status in anaplastic thyroid carcinoma Lee, Dae Ho; Lee, Geon Kook; Kong, Sun-Young; Kook, Myoung Chul; Yang, Sun Kyung; Park, So Yeon; Park, Seong Hoe; Keam, Bhumsuk; Park, Do Joon; Cho, Bo Youn; Kim, Seok Won; Chung, Ki-Wook; Lee, Eun Sook; Kim, Sun Wook J Clin Pathol. 2007 Aug;60(8):881-4. Epub 2006 Nov 1.	link
2016-03	A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) Lim, Sun Min; Cho, Byoung Chul; Kim, Sang-We; Kang, Seok Yun; Heo, Dae Seog; Kim, Heung Tae; Lee, Dae Ho; Kim, Dong-Wan; Jung, Minkyu; Choi, Jin-Hyuk; Shim, Hyo Sup; Choi, Jong Rak; Kim, Joo-Hang Lung Cancer, Vol.93, pp.1-8	DOI
2017-02	A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Kim, Hye Ryun; Jang, Joung Soon; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Jung, Inkyung; Lee, Ki Hyeong; Kim, Joo-Hang; Lee, Dae Ho; Kim, Sang-We; Cho, Byoung Chul Oncotarget, Vol.8 No.9, pp.15943-15951	view file DOI
2018-02	Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors Lee, Keun-Wook; Lee, Dae Ho; Kang, Jin Hyoung; Park, Joon Oh; Kim, Se Hyun; Hong, Yong Sang; Kim, Seung Tae; Oh, Do-Youn; Bang, Yung-Jue Oncologist, Vol.23 No.2, pp.155-e17	DOI
2018-09	Exploratory analysis of brigatinib activity in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer and brain metastases in two clinical trials Camidge, D. Ross; Kim, Dong-Wan; Tiseo, Marcello; Langer, Corey J.; Ahn, Myung-Ju; Shaw, Alice T.; Huber, Rudolf M.; Hochmair, Maximilian J.; Lee, Dae Ho; Bazhenova, Lyudmila A.; Gold, Kathryn A.; Ou, Sai-Hong Ignatius; West, Howard L.; Reichmann, William; Haney, Jeff; Clackson, Tim; Kerstein, David; Gettinger, Scott N. Journal of Clinical Oncology, Vol.36 No.26, pp.2693-2701	DOI
2018-11	Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel S. W. Journal of Clinical Oncology, Vol.36 No.31, pp.3101-3109	DOI
2019-09	Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial Kim, Dong-Wan; Lee, Dae Ho; Han, Ji-Youn; Lee, Jongseok; Cho, Byoung Chul; Kang, Jin Hyoung; Lee, Ki Hyeong; Cho, Eun Kyung; Kim, Jin-Soo; Min, Young Joo; Cho, Jae Yong; An, Ho Jung; Kim, Hoon-Gu; Lee, Kyung Hee; Kim, Bong-Seog; Jang, In-Jin; Yoon, Seonghae; Han, OakPil; Noh, Young Su; Hong, Ka Young; Park, Keunchil Lung Cancer, Vol.135, pp.66-72	DOI
2019-12	Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study Ahn, Myung-Ju; Han, Ji-Youn; Lee, Ki Hyeong; Kim, Sang-We; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok; Min, Young Joo; Kim, Jin-Soo; Lee, Sung Sook; Kim, Hye Ryun; Hong, Min Hee; Ahn, Jin Seok; Sun, Jong-Mu; Kim, Heung Tae; Lee, Dae Ho; Kim, Sohee; Cho, Byoung Chul The Lancet Oncology, Vol.20 No.12, pp.1681-1690	DOI
2021-05	Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, Hyunjin; Baek, Eunhye; Noh, Young Su Cancer, Vol.127 No.9, pp.1407-1416
2021-07	Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study Gainor, Justin F.; Curigliano, Giuseppe; Kim, Dong-Wan; Lee, Dae Ho; Besse, Benjamin; Baik, Christina S.; Doebele, Robert C.; Cassier, Philippe A.; Lopes, Gilberto; Tan, Daniel S. W.; Garralda, Elena; Paz-Ares, Luis G.; Cho, Byoung Chul; Gadgeel, Shirish M.; Thomas, Michael; Liu, Stephen, V; Taylor, Matthew H.; Mansfield, Aaron S.; Zhu, Viola W.; Clifford, Corinne; Zhang, Hui; Palmer, Michael; Green, Jennifer; Turner, Christopher D.; Subbiah, Vivek The Lancet Oncology, Vol.22 No.7, pp.959-969	DOI
2021-09	Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer Cho, Byoung Chul; Yoh, Kiyotaka; Perets, Ruth; Nagrial, Adnan; Spigel, David R.; Gutierrez, Martin; Kim, Dong-Wan; Kotasek, Dusan; Rasco, Drew; Niu, Jiaxin; Satouchi, Miyako; Ahn, Myung-Ju; Lee, Dae Ho; Maurice-Dror, Corinne; Siddiqi, Shabana; Ren, Yixin; Altura, Rachel A.; Bar, Jair Lung Cancer, Vol.159, pp.162-170	DOI
2022-07	Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14 Kim, Ok-Hee; Kang, Geun-Hyung; Hur, June; Lee, Jinwook; Jung, YunJae; Hong, In-Sun; Lee, Hookeun; Seo, Seung-Yong; Lee, Dae Ho; Lee, Cheol Soon; Lee, In-Kyu; Bonner-Weir, Susan; Lee, Jongsoon; Park, Young Joo; Kim, Hyeonjin; Shoelson, Steven E.; Oh, Byung-Chul Cell Death and Differentiation, Vol.29 No.7, pp.1423-1432	DOI

1

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN